Certara stock.

About Certara Certara accelerates medicines using biosimulation software, technology and services to transform traditional drug discovery and development. Its clients include more than 2,300 biopharmaceutical companies, academic institutions, and regulatory agencies across 70 countries. Learn more at Certara.com. Certara Contact:Discover historical prices for CERT stock on Yahoo Finance. View daily, weekly or monthly format back to when Certara, Inc. stock was issued. ... Certara, Inc. (CERT) NasdaqGS - NasdaqGS Real Time ...Why Certara. Responsibility. Certara is committed to understanding, monitoring, and managing our social and environmental responsibilities. Regulatory Adoption. Many global regulatory agencies have adopted use of Certara’s Simcyp PBPK and Phoenix PK/PD platforms. Locations. Discover our global office locations. LeadershipDec 1, 2023 · According to the issued ratings of 8 analysts in the last year, the consensus rating for Certara stock is Hold based on the current 5 hold ratings and 3 buy ratings for CERT. The average twelve-month price prediction for Certara is $19.71 with a high price target of $24.00 and a low price target of $16.00. Learn more on CERT's analyst rating ...

Success is Achieved Together. Biosimulation can reduce the size of and cost of human trials, the most expensive and time-consuming part of drug development. In some cases, we can eliminate certain human trials completely. More than 2,000 customers worldwide choose us as their partner for biosimulation software and technology-driven services.

The average twelve-month price prediction for Palantir Technologies is $13.25 with a high price target of $25.00 and a low price target of $5.00. Learn more on PLTR's analyst rating history. Do Wall Street analysts like Palantir Technologies more than its competitors? Analysts like Palantir Technologies less than other Business Services …Certara Inc Follow Share $14.64 After Hours: $14.64 (0.00%) 0.00 Closed: Dec 1, 4:03:07 PM GMT-5 · USD · NASDAQ · Disclaimer search Compare to Exscientia PLC $6.17 EXAI1.15% Amazon.com Inc...

Certara, Inc. (CERT) came out with quarterly earnings of $0.11 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.10 per share a year ago. These figures are ...Certara (CERT) stock rose ~15% on Thursday after Q4 results beat estimates and the company's FY23 outlook range surpassed analysts expectations.Adjusted EPS grew +166.6% Y/Y to $0.16,...The estimated Net Worth of William F Feehery is at least $75.5 million dollars as of 31 March 2023. Dr Feehery owns over 36,580 units of Certara stock worth over $42,281,189 and over the last 11 years he sold CERT stock worth over $31,782,752. In addition, he makes $1,387,564 as CEO & Director at Certara.

5.27 M Change from Last -18.62% Percent of Float 4.84% Research & Ratings Certara Inc. Per-Share Earnings, Actuals and Estimates Actual Analyst Range Consensus More View the latest Certara Inc....

Robert has made over 7 trades of the Certara stock since 2021, according to the Form 4 filled with the SEC. Most recently Robert exercised 8,646 units of CERT stock worth $166,436 on 31 March 2023.

11 Des 2020 ... Certara CEO on strong IPO debut. CNBC's “Squawk Alley” team ... Global Business and Financial News, Stock Quotes, and Market Data and Analysis.Oct 17, 2023 · With Certara, Inc. shares trading a bit north of 30 times earnings and nearly 6.5 times forward sales, there is nothing compelling about the stock's current valuation given Certara's projected ... The new Simcyp Discovery Simulator is an intuitive PBPK software that delivers confidence in decision-making during the pre-Investigational New Drug (IND) Application and translational stages. Derived from the gold-standard Simcyp Simulator, Simcyp Discovery advances and accelerates small molecule discovery and development.Find the latest TETRA Technologies, Inc. (TTI) stock quote, history, news and other vital information to help you with your stock trading and investing.OPKO Health Inc. 1.53. +0.07. +4.79%. Get Certara Inc (CERT:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.

Oct 11, 2023 · PRINCETON, N.J, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the third quarter of 2023 after the market close on Wednesday November 8 th , 2023. Arena Pharmaceuticals. 22-Feb-1999. Later Stage VC. 0000. Completed. 5 buyers. To view Certara’s complete exits history, request access ». Information on stock, financials, earnings, subsidiaries, investors, and executives for Certara. Use the PitchBook Platform to explore the full profile.11 Okt 2023 ... 11, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial ...Nasdaq | CERT U.S.: Nasdaq Certara Inc. Watch list NEW Set a price target alert After Hours Last Updated: Nov 24, 2023 2:28 p.m. EST Delayed quote $ 15.20 0.23 1.54% After Hours Volume: 2.55K... When it comes to purchasing a new vehicle, finding the perfect car that meets all your requirements can be a daunting task. If you have your heart set on a Genesis GV70, you’ll want to ensure that you find the best one available in stock.Certara Inc. (NASDAQ:NASDAQ:CERT) Q3 2023 Earnings Conference Call November 8, 2023 5:00 PM ETCompany ParticipantsDavid Deuchler - Investor Relations...

The average twelve-month price prediction for Palantir Technologies is $13.25 with a high price target of $25.00 and a low price target of $5.00. Learn more on PLTR's analyst rating history. Do Wall Street analysts like Palantir Technologies more than its competitors? Analysts like Palantir Technologies less than other Business Services …

Mar 17, 2023 · In terms of valuation, Certara Inc. stock appears to be trading at a premium compared to its peers in the same industry. The company's market capitalization stands at approximately $3.1 billion ... Those who successfully complete the certification courses will earn the following certifications: Certara Certified NCA Analyst using Phoenix WinNonlin Version 8.3 Certara Certified PK/PD Modeler using Phoenix WinNonlin 8.4 This bundle includes four courses: two conceptual courses (delivered in e-learning format) and two certification courses ...The estimated Net Worth of William F Feehery is at least $78.7 Millón dollars as of 31 March 2023. Dr Feehery owns over 36,580 units of Certara stock worth over $45,530,211 and over the last 11 years he sold CERT stock worth over $31,782,752. In addition, he makes $1,387,564 as CEO & Director at Certara.Michael Schemick CERT stock SEC Form 4 insiders trading. Michael has made over 8 trades of the Certara stock since 2019, according to the Form 4 filled with the SEC. Most recently Michael exercised 13,302 units of CERT stock worth $199,131 on 31 March 2023.. The largest trade Michael's ever made was selling 66,667 units of Certara …Certara Inc. (NASDAQ:NASDAQ:CERT) Q3 2023 Earnings Conference Call November 8, 2023 5:00 PM ETCompany ParticipantsDavid Deuchler - Investor Relations...The estimated Net Worth of Leif E Pedersen is at least $6.02 Million dollars as of 31 March 2023. Mr Pedersen owns over 8,646 units of Certara stock worth over $3,161,396 and over the last 2 years he sold CERT stock worth over $2,563,711. In addition, he makes $295,397 as Pres of Software at Certara.

Smart Screens. Smart Screens Search stocks using 100s of variables and make your own screens

May 8, 2023 · Certara, Inc. (CERT) delivered earnings and revenue surprises of 0% and 1.14%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Nov 8, 2023 · Certara, Inc. (CERT) delivered earnings and revenue surprises of 0% and 0.45%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock? CERT Certara, Inc. Stock Price & Overview 2.67K followers $14.64 0.23 ( +1.60%) 4:00 PM 12/01/23 NASDAQ | $USD | Post-Market: $14.64 4:03 PM Summary …Certara (CERT) stock rose ~15% on Thursday after Q4 results beat estimates and the company's FY23 outlook range surpassed analysts expectations.Adjusted EPS grew +166.6% Y/Y to $0.16,...Insiders trading at Certara. Over the last 4 years, insiders at Certara have traded over $2,047,095,989 worth of Certara stock and bought 97,245 units worth $1,908,085 . The most active insiders traders include Avatar Parent L.P.Eqt Avata..., James E Iii Cashman, and Mason P Slaine.On average, Certara executives and independent …Find the latest Telos Corporation (TLS) stock quote, history, news and other vital information to help you with your stock trading and investing.View the latest Certara Inc. (CERT) stock price, news, historical charts, analyst ratings and financial information from WSJ. Why Certara. Responsibility. Certara is committed to understanding, monitoring, and managing our social and environmental responsibilities. Regulatory Adoption. Many global regulatory agencies have adopted use of Certara’s Simcyp PBPK and Phoenix PK/PD platforms. Locations. Discover our global office locations. Leadership110 Salaries (for 72 job titles) • Updated Nov 20, 2023. How much do Certara employees make? Glassdoor provides our best prediction for total pay in today's job market, along with other types of pay like cash bonuses, stock bonuses, profit sharing, sales commissions, and tips. Our model gets smarter over time as more people share …Stock control is important because it prevents retailers from running out of products, according to the Houston Chronicle. Stock control also helps retailers keep track of goods that may have been lost or stolen.Overall, Nice Ltd (ADR) stock has a Value Score of 17, Growth Score of 97 and Quality Score of 94. Certara Inc stock has a Value Score of 14, Growth Score of 50 and Quality Score of 58. Comparing Nice Ltd (ADR) and Certara Inc’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not.

Reiterating 2023 Financial Outlook. Certara continues to expect the following: Full year 2023 revenue to be in the range of $370 million to $385 million. Full year 2023 adjusted EBITDA to be in the range of $131 million to $137 million. Full year adjusted diluted earnings per share to be in the range of $0.50 - $0.55.Mar 24, 2021 · Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the pricing of its underwritten public offering of 10 million shares of its common stock by certain existing stockholders (“the selling stockholders”) at a price to the public of $25.00 per share. Additionally, the selling stockholders have granted the ... 10 Des 2020 ... (Reuters) -U.S. drug development consultancy Certara Inc said on Thursday it sold shares in its initial public offering at $23 apiece, ...The half-life of the drug is the time to eliminate 50% of the drug in the body. In this case, the 5th molecule is eliminated at 60.0 minutes. The MRT is calculated by summing the total time in the body and dividing by the number of molecules, which is turns out to be 85.6 minutes. Thus MRT represents the average time a molecule stays in the …Instagram:https://instagram. average 401k match by industrym1 cryptofactor etfsoil future contract prices According to the issued ratings of 8 analysts in the last year, the consensus rating for Certara stock is Hold based on the current 5 hold ratings and 3 buy ratings for CERT. The average twelve-month price prediction for Certara is $19.71 with a high price target of $24.00 and a low price target of $16.00. Learn more on CERT's analyst rating ...Exhibit 10.21 . CERTARA, INC. 2020 EMPLOYEE STOCK PURCHASE PLAN . 1. Purpose.The purpose of the Plan is to provide a means by which Eligible Employees may purchase Common Stock, thereby strengthening their commitment to the welfare of the Company and its Designated Companies and aligning their interests with those of the … cobalt mining companies stockgold royalty stocks Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets.Certara, Inc. is a provider of biosimulation software and technology-enabled services. The Company is focused on producing medicines for patients using biosimulation software, technology, and services to transform traditional drug discovery and development. signals forex The estimated Net Worth of William F Feehery is at least $64.1 Million dollars as of 31 March 2023. Dr Feehery owns over 36,580 units of Certara stock worth over $30,975,471 and over the last 11 years he sold CERT stock worth over $31,782,752. In addition, he makes $1,387,564 as CEO & Director at Certara.Certara Inc Registered Shs Aktie Profil Die Certara Inc Registered Shs Aktie wird unter der ISIN US15687V1098 an den Börsen Hamburg, Berlin, NASDAQ, Bats, NASDAQ Bsc, Tradegate und Lang & Schwarz ...